5 (647) · $ 11.00 · In stock
Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group, Arthritis Research & Therapy
Understanding Remission: Insights from Patients and Rheums
DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability
Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission
What Remission and Low Disease Activity in RA Means
Remission Definitions in RA: Common Questions & Implications for Clinical Practice - The Rheumatologist
Frontiers Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations
DAS28 May Be Inaccurate in Older Rheumatoid Arthritis Patients
Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?, Arthritis Research & Therapy
Disease activity measures used in RA. This shows the components and